Enhancing the QUAlity and Transparency Of health Research
In response to a long fought for policy change at the European Medicines Agency requiring publication of all relevant trial clinical study reports which came into force on 1 January 2015 and a new European Union Clinical Trials Regulation due to come into effect from May 2016, the BMJ has published a feature highlighting the key people involved in helping to bring about this important increase in transparency, including those who campaigned for change and those who listened and acted.
Of the people included in the list, Doug Altman is a co-founder of the EQUATOR Network and both Iain Chalmers and Kay Dickersin have in the past presented our EQUATOR Annual Lectures.
Read the BMJ feature at:
How can reporting quality interfere with reproducibility issues and overall trust in science results? With that question in mind, we participated in the Reproducibility, Replicability and Trust in Science conference organised by the Wellcome Genome Campus from 9 to 11...